Avalon Pharma (Middle East Pharmaceutical)
4016.SR
#7076
Rank
NZ$1.11 B
Marketcap
NZ$31.77
Share price
-0.91%
Change (1 day)
-45.80%
Change (1 year)

EPS for Avalon Pharma (Middle East Pharmaceutical) (4016.SR)

EPS in 2026 (TTM): NZ$0.87

According to Avalon Pharma (Middle East Pharmaceutical)'s latest financial reports the company's current EPS (TTM) is NZ$0.92. In 2025 the company made an earnings per share (EPS) of NZ$1.35 an increase over its 2024 EPS that were of NZ$1.11.

EPS history for Avalon Pharma (Middle East Pharmaceutical) from 2023 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$0.87-35.82%
2025NZ$1.3521.69%
2024NZ$1.1121.02%
2023NZ$0.92